Avinger announces key opinion leader presentations at vascular conferences in germany

Redwood city, ca / accesswire / june 28, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced key opinion leader (kol) presentations featuring the company's lumivascular technology at two important vascular conferences held in germany: the annual german cli congress and the essen vascular conference. dr. arne schwindt, a vascular surgeon from st. franziskus hospital mÜnster in germany, gave a presentation featuring avinger's lumivascular technology at the annual critical limb ischemia (cli) congress in germany.
AVGR Ratings Summary
AVGR Quant Ranking